SplashBIO™ Inc., a biomarker-driven enrollment infrastructure platform for clinical trials, today announced its launch as an independent company. Spun out from Splash Clinical — the enrollment ...

Wauwasota, WI, and Cambridge, UK, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Splash Clinical, the new standard in patient recruitment solutions, and Cambridge Cognition (AIM: COG), a leading provider of ...

Splash Clinical and C2N Diagnostics have collaborated to enhance the recruitment process for clinical trials of Alzheimer's disease across the US and worldwide. This collaboration involves a clinical ...

Splash Clinical's solutions extend across the complete patient journey. We've shaped our offerings to transform all three critical phases of trial success: pre-enrollment planning, recruitment and ...

WAUWATOSA, Wis., June 17, 2025 (GLOBE NEWSWIRE) -- Splash Clinical, the new standard in trial enrollment, announced today the introduction of SplashBIO™, a proprietary biomarker platform for clinical ...

Spun out from Splash Clinical, SplashBIO brings biomarker pre-screening to the front of the clinical trial - built to reduce screen failures and accelerate enrollment. The newly independent company wi ...

A customizable platform that uses biomarker tests to accelerate enrollment, save money, and reduce screen failure rates. WAUWATOSA, Wis., June 17, 2025 (GLOBE NEWSWIRE) -- Splash Clinical, the new ...

(MENAFN- GlobeNewsWire - Nasdaq) The first-of-its-kind partnership combines Splash's recruitment platform with C2N's innovative blood tests to accelerate clinical research and improve patient ...